Literature DB >> 6185766

Myocardial concentration of norepinephrine and cyclic AMP in ventricular fibrillation during acute myocardial ischemia.

H Kanayama, M Ban, K Ogawa, T Satake.   

Abstract

To clarify the relationship between the concentrations of norepinephrine (NE) and cyclic AMP (c-AMP) in the myocardium and the incidence of ventricular fibrillation (VF), we studied 48 dogs in which VF was induced by the ligation of the left anterior descending coronary artery. The animals were divided into two groups of equal size: The first received no drugs, the second received d,l-propranolol (0.5 mg/kg) 15 min before coronary ligation. Myocardial samples were taken at regular intervals from normal and ischemic areas to determine NE and c-AMP concentrations. In the untreated group, no significant change in the concentrations of NE and c-AMP was observed in 12 dogs that did not develop VF. In the other 12 dogs that developed VF, there was a significant increase in c-AMP in the ischemic area immediately after the onset of the dysrhythmia. A significant increase in NE concentration both in normal and ischemic myocardium was observed in only 8 of these latter 12 dogs. Premedication with propranolol significantly reduced the incidence of VF, but it still occurred in 5 out of 24 dogs. Increase in c-AMP without an increase in NE in ischemic area was observed in these five dogs. These results suggest that c-AMP may play a role in the development of VF during acute ischemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185766     DOI: 10.1097/00005344-198211000-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure.

Authors:  H N Sabbah; W Haddad; Y Mika; O Nass; R Aviv; V G Sharov; V Maltsev; B Felzen; A I Undrovinas; S Goldstein; N Darvish; S A Ben-Haim
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

2.  Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.

Authors:  B G Benfey; M S Elfellah; R I Ogilvie; D R Varma
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

3.  Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.

Authors:  D Baumgart; T Ehring; M Krajcar; A Skyschally; G Heusch
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

4.  Antiarrhythmic effects of DPI 201-106.

Authors:  G Scholtysik; F M Williams
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

5.  DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.

Authors:  G Scholtysik; R Salzmann; R Berthold; J W Herzig; U Quast; R Markstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

6.  Altered myocardial acetylcholine and norepinephrine concentrations in right ventricular hypertrophy and failure.

Authors:  Y Yamada; K Okumura; H Hashimoto; T Ito; T Satake
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.